A miR-340/SPP1 axis inhibits the activation and proliferation of hepatic stellate cells by inhibiting the TGF-β1/Smads pathway
Advances in Clinical and Experimental Medicine · 2022
DOI: 10.17219/acem/154996 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical and Experimental Medicine, 2022. Verfasst von Ronghua Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China. Hauptthemen laut MEDLINE: MicroRNAs, Transforming Growth Factor beta1. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hebei Key Laboratory for Chronic Diseases, School of Basic Medical Sciences, North China University of Science and Technology, Tangshan, China.
- School of Clinical Medicine, North China University of Science and Technology, Tangshan, China.
- Health Science Center, North China University of Science and Technology, Tangshan, China.
- Gastroenterology Department, Tangshan Paraplegia Sanatorium, China.
- Tianjin Key Laboratory of Early Druggability Evaluation of Innovative Drugs, Tianjin International Joint Academy of Biomedicine, China.
- The Cancer Institute, Hebei Key Laboratory of Molecular Oncology, Tangshan People's Hospital, China.
Zitieren
APA
Zhang, R., Wang, M., Lu, H., Wang, J., Han, X., Liu, Z., Li, L., Li, M., Tian, X., Chen, S., Zhang, G., Xiong, Y., & Li, J. (2022). A miR-340/SPP1 axis inhibits the activation and proliferation of hepatic stellate cells by inhibiting the TGF-β1/Smads pathway. Advances in Clinical and Experimental Medicine. https://doi.org/10.17219/acem/154996
Vancouver
Zhang R, Wang M, Lu H, Wang J, Han X, Liu Z, et al. A miR-340/SPP1 axis inhibits the activation and proliferation of hepatic stellate cells by inhibiting the TGF-β1/Smads pathway. Advances in Clinical and Experimental Medicine. 2022. doi:10.17219/acem/154996
BibTeX
@article{Zhang2022,
author = {Zhang, Ronghua and Wang, Meimei and Lu, Hongjian and Wang, Jingyao and Han, Xiangyang and Liu, Zhiyong and Li, Lin and Li, Mingming and Tian, Xiaoli and Chen, Shuang and Zhang, Guangling and Xiong, Yanan and Li, Jingwu},
title = {A miR-340/SPP1 axis inhibits the activation and proliferation of hepatic stellate cells by inhibiting the TGF-β1/Smads pathway},
journal = {Advances in Clinical and Experimental Medicine},
year = {2022},
doi = {10.17219/acem/154996}
}
EUVIMED